Followers | 128 |
Posts | 23648 |
Boards Moderated | 1 |
Alias Born | 09/14/2016 |
Tuesday, September 14, 2021 9:42:55 AM
https://finance.yahoo.com/news/gain-therapeutics-present-2021-international-202000645.html
Recent GANX News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 09:22:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:30:26 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/19/2024 10:15:40 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/06/2024 09:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 09:00:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:05:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:03:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:24:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 09:18:46 PM
- Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024 • GlobeNewswire Inc. • 06/28/2024 08:39:04 PM
- Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO • GlobeNewswire Inc. • 06/27/2024 08:08:08 PM
- Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease • GlobeNewswire Inc. • 06/27/2024 12:35:48 PM
- Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/25/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/17/2024 12:30:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:40:23 PM
- Gain Therapeutics Announces Pricing of $11.0 Million Public Offering • GlobeNewswire Inc. • 06/14/2024 01:00:59 AM
- Gain Therapeutics Announces Proposed Public Offering • GlobeNewswire Inc. • 06/13/2024 08:44:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/13/2024 08:38:54 PM
- Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024 • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:06:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:03:12 PM
- Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease • GlobeNewswire Inc. • 04/24/2024 01:25:00 PM
- Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer • GlobeNewswire Inc. • 04/08/2024 01:25:00 PM
- Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer • GlobeNewswire Inc. • 04/01/2024 01:25:00 PM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM